AU2169799A - Pharmaceutical composition for nasal administration of thiocolchicoside - Google Patents

Pharmaceutical composition for nasal administration of thiocolchicoside

Info

Publication number
AU2169799A
AU2169799A AU21697/99A AU2169799A AU2169799A AU 2169799 A AU2169799 A AU 2169799A AU 21697/99 A AU21697/99 A AU 21697/99A AU 2169799 A AU2169799 A AU 2169799A AU 2169799 A AU2169799 A AU 2169799A
Authority
AU
Australia
Prior art keywords
thiocolchicoside
pharmaceutical composition
nasal administration
immediate
nasal
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU21697/99A
Inventor
Mariella Artusi
Paolo Colombo
Patrizia Santi
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sanofi Aventis France
Original Assignee
Sanofi Synthelabo SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sanofi Synthelabo SA filed Critical Sanofi Synthelabo SA
Publication of AU2169799A publication Critical patent/AU2169799A/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/70Carbohydrates; Sugars; Derivatives thereof
    • A61K31/7028Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages
    • A61K31/7034Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin
    • A61K31/704Compounds having saccharide radicals attached to non-saccharide compounds by glycosidic linkages attached to a carbocyclic compound, e.g. phloridzin attached to a condensed carbocyclic ring system, e.g. sennosides, thiocolchicosides, escin, daunorubicin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0012Galenical forms characterised by the site of application
    • A61K9/0043Nose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/36Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin
    • A61K47/40Cyclodextrins; Derivatives thereof

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Otolaryngology (AREA)
  • Molecular Biology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Saccharide Compounds (AREA)

Abstract

The invention concerns a pharmaceutical composition for nasal administration of thiocolchicoside, with immediate or sustained release.
AU21697/99A 1998-02-05 1999-02-02 Pharmaceutical composition for nasal administration of thiocolchicoside Abandoned AU2169799A (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
FR9801328 1998-02-05
FR9801328A FR2774290B1 (en) 1998-02-05 1998-02-05 PHARMACEUTICAL COMPOSITION FOR NASAL ADMINISTRATION OF THIOCOLCHICOSIDE
PCT/FR1999/000204 WO1999039717A1 (en) 1998-02-05 1999-02-02 Pharmaceutical composition for nasal administration of thiocolchicoside

Publications (1)

Publication Number Publication Date
AU2169799A true AU2169799A (en) 1999-08-23

Family

ID=9522615

Family Applications (1)

Application Number Title Priority Date Filing Date
AU21697/99A Abandoned AU2169799A (en) 1998-02-05 1999-02-02 Pharmaceutical composition for nasal administration of thiocolchicoside

Country Status (9)

Country Link
EP (1) EP1052995B1 (en)
AT (1) ATE227997T1 (en)
AU (1) AU2169799A (en)
DE (1) DE69904020T2 (en)
DK (1) DK1052995T3 (en)
ES (1) ES2187136T3 (en)
FR (1) FR2774290B1 (en)
PT (1) PT1052995E (en)
WO (1) WO1999039717A1 (en)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TR200708925A1 (en) 2007-12-26 2009-07-21 Sanovel İlaç Sanayi̇ Ve Ti̇caret Anoni̇m Şi̇rketi̇ Combinations of flurbiprofen and muscle relaxants for controlled release
TR201001903A2 (en) 2010-03-12 2011-04-21 Ali̇ Rai̇f İlaç Sanayi̇ Ve Ti̇caret A.Ş. Extended release thiocolchicoside tablet.
ES2577130T3 (en) 2013-09-12 2016-07-13 Sanovel Ilac Sanayi Ve Ticaret A.S. New formulations of thiocolchicósido
HUE029193T2 (en) 2013-09-12 2017-02-28 Sanovel Ilac Sanayi Ve Ticaret As Sustained release pharmaceutical formulations of Thiocolchicoside

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1345991A (en) * 1972-05-05 1974-02-06 Roussel Uclaf Thiocolchicine derivatives
IT1275955B1 (en) * 1995-03-22 1997-10-24 Dompe Spa PHARMACEUTICAL FORMULATIONS IN THE FORM OF THISSOTROPIC GEL
IT1276996B1 (en) * 1995-06-27 1997-11-04 Indena Spa COLCHICINE DERIVATIVES, THEIR USE AND FORMULATIONS CONTAINING THEM
IT1283110B1 (en) * 1996-06-07 1998-04-07 Indena Spa COLCHYCINE SKELETON COMPOUNDS, THEIR USE AS DRUGS AND COMPOSITIONS THAT CONTAIN THEM
FR2759587B1 (en) * 1997-02-20 1999-03-19 Synthelabo PHARMACEUTICAL COMPOSITION FOR THE ORAL ADMINISTRATION OF THIOCOLCHICOSIDE

Also Published As

Publication number Publication date
ATE227997T1 (en) 2002-12-15
FR2774290B1 (en) 2000-06-16
DE69904020T2 (en) 2004-03-04
ES2187136T3 (en) 2003-05-16
DE69904020D1 (en) 2003-01-02
EP1052995B1 (en) 2002-11-20
WO1999039717A1 (en) 1999-08-12
PT1052995E (en) 2003-03-31
EP1052995A1 (en) 2000-11-22
DK1052995T3 (en) 2003-03-17
FR2774290A1 (en) 1999-08-06

Similar Documents

Publication Publication Date Title
TW430562B (en) Controlled release of drugs delivered by sublingual or buccal administration
AP9901534A0 (en) Pharmaceutical formulations.
GR3035548T3 (en) Controlled release of drugs delivered by sublingual or buccal administration
AU5914999A (en) Controlled release drug delivery
AU3733399A (en) Drug composites
EP1193270A3 (en) Pyrrolobenzodiazepines
MY118151A (en) Pharmaceutical formulations containing voriconazole.
IL133397A0 (en) Pharmaceutical compositions for oral administration, comprising an active substance and a cyclodextrin
HK1030218A1 (en) Novel 2-(iminomethyl)amino-phenyl derivatives, preparation, application as medicines and compositions containing same.
AU4155897A (en) Cytotoxic amino sugar and related sugar derivatives of indolopyrrolocarbazoles
WO2001045678A3 (en) Medicament, a method for its production and the use thereof
TW200716550A (en) Pharmaceutical composition comprising ritonavir
AU5892399A (en) 1, 2, 4-triazole-3-thione compounds
MY126868A (en) Suspension comprising oxcarbazepine
CA2317954A1 (en) Device for coating granules to be administered orally
WO2001078682A3 (en) Sustained release drug compositions
BG101401A (en) Cisaspide extended release oral compositions
AU2001258443A1 (en) Drug delivery device, especially for the delivery of gestodene
AU2169799A (en) Pharmaceutical composition for nasal administration of thiocolchicoside
AU2001258442A1 (en) Drug delivery device, especially for the delivery of levonorgestrel
AU6404798A (en) Pharmaceutical composition for the administration of thiocolchicoside via the buccal mucosa
AU2002222695A1 (en) Novel 4'-demethyl-4'-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same
DE69818492D1 (en) 7-methylthiooxomethyl- und 7-methylthiodioxomethyl-paclitaxele
AU1230800A (en) Controlled delivery of antidepressants
WO2000017366A3 (en) Pharmaceutical composition for the pre-treatment of a patient in need of drug or pro-drug

Legal Events

Date Code Title Description
MK6 Application lapsed section 142(2)(f)/reg. 8.3(3) - pct applic. not entering national phase